NOVELTY Everolimus Eluting Coronary Stent System is the latest in the second generation of drug eluting stents, an ultimate combination of three outstanding elements: a clinically proven drug – Everolimus, a modified Cobalt Chromium stent platform, and an excellent bioabsorbable drug carrier.
NOVELTY takes the ideal definition of Safety – Efficiency – Deliverability for Percutaneous Coronary Intervention (PCI) to a higher level, convinces with its trusted technology and largest size portfolio available, provides high end performance with less metallic coverage but reliable outcomes, and offers an optimal solution for improving luminal diameter and reducing in-stent restenosis when treating coronary artery lesions.
